Back to all papers

Deep Learning for Pretreatment Imaging-Based Tumor and Nodal Classification in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis.

April 29, 2026pubmed logopapers

Authors

Ketschau J,Grabenhorst A,Singer H,Brandt J,Kram H,Krautkremer N,Miragall MF,Pippich K,Mohr J,Wolff KD,Ritschl LM

Affiliations (2)

  • Department of Oral and Maxillofacial Surgery, TUM University Hospital Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Chair for AI in Healthcare and Medicine, Technical University of Munich (TUM) and TUM University Hospital, Munich, Germany.

Abstract

Accurate pretreatment assessment of the extent of tumor invasion and status of cervical lymph node metastasis is essential for staging and treatment planning in HNSCC. Deep learning (DL) shows promise but is limited by methodological heterogeneity. We conducted a systematic review and network meta-analysis (PRISMA). Studies (2019-2025) evaluating DL models for pretreatment lymph node or tumor invasion classification using CT, MRI, PET/CT, or SPECT/CT were included. Diagnostic performance (AUC) was pooled using random-effects models. Twenty-three studies were included. Pooled AUC for lymph node classification was 0.78 (95% CI 0.72-0.84). In subgroup analyses, performance was lower in multicenter and externally validated studies (AUC 0.84) than in single-center studies (AUC 0.92; p = 0.029), and slightly lower with radiologic versus pathologic ground truth (0.83 vs. 0.87; p = 0.093). Network meta-analysis showed a nonsignificant advantage of fusion models. Pooled AUC for tumor invasion was 0.84. DL models outperformed human readers (ΔAUC +0.09). DL demonstrates strong diagnostic performance for pretherapeutic HNSCC imaging, but results depend on study design. Standardized datasets and prospective multicenter validation are required.

Topics

Journal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.